ArticlePloS one2025
The Temporal pathological changes of venous catheter-related fibrin sheath and their implications for nursing practice.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the time-sequential variation patterns of the impact of venous catheter-related fibrin sheath (FS) on blood vessels during the ultra-early period (12 hours to 4 days) after catheterization, and provide a basis for optimizing clinical catheter management strategies.
methodsA rabbit ear marginal vein indwelling catheter model (n = 40) was established and randomly divided into 12h, 1d, 2d, 3d, and 4d indwelling groups (8 rabbits per group). After sampling, Hematoxylin-Eosin (HE) staining was performed to systematically evaluate infusion patency, FS thickness, FS structural integrity, thrombus area, inflammatory cell infiltration, and venous edema. Welch's ANOVA, trend tests, and Spearman correlation analysis were used for data analysis.
resultsThe patency of the catheters decreased significantly with increasing indwelling time (p < 0.001), with the rate dropping from 87.5% at 12 hours to 0% at 4 days, accompanied by a complete blockage rate of 75.0% at the latter time point. Concurrently, the thrombus area exhibited an extremely significant increase (p < 0.001), from 0.12 ± 0.03 mm² at 12h to 1.86 ± 0.20 mm² at 4 days (η² = 0.976). Regarding the fibrin sheath (FS), its thickness increased extremely significantly (p < 0.001) from 23.5 ± 4.2 μm at 12h to 156.7 ± 10.8 μm at 4 days (η² = 0.986). Furthermore, the integrity of the FS improved over time (p < 0.001), shifting from a state of predominantly incomplete continuity (87.5%) at 12h to predominantly complete continuity (87.5%) at 4 days.The inflammatory response intensified markedly, with the inflammatory cell count significantly increasing from 12.3 ± 2.5 cells/field at 12h to 85.4 ± 6.3 cells/field at 4 days (p < 0.001). The proportion of samples exhibiting severe inflammation rose from 0% to 62.5% (p < 0.001). Similarly, the degree of venous edema worsened significantly (p < 0.001), shifting from predominantly mild edema (62.5%) at 12h to severe edema (62.5%) at 4 days.Key time nodes were identified: 48 hours represented a critical point, characterized by a thrombus area >0.75 mm², FS thickness >78 μm, and a prevalence of moderate-to-severe inflammation and edema exceeding 75%. By 72 hours, a high-risk point was observed, marked by a complete blockage rate >50%, severe edema >25%, and FS complete rupture >50%.
conclusionFS rapidly forms and dynamically evolves during the ultra-early period after catheterization, leading to time-dependent exacerbation of mechanical obstruction, thrombosis, and vascular inflammatory injury. The study identifies 48-72 hours as a critical intervention window, recommending enhanced clinical assessment and timely intervention (e.g., optimizing catheter replacement timing) to reduce the risk of catheter-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.